Published in Lab Invest on February 13, 2012
Tracking immune cells in vivo using magnetic resonance imaging. Nat Rev Immunol (2013) 2.05
Seeing stem cells at work in vivo. Stem Cell Rev (2014) 1.28
In vivo MRI cell tracking using perfluorocarbon probes and fluorine-19 detection. NMR Biomed (2013) 1.25
A novel probe for the non-invasive detection of tumor-associated inflammation. Oncoimmunology (2013) 1.05
In vivo MR detection of fluorine-labeled human MSC using the bSSFP sequence. Int J Nanomedicine (2014) 0.89
Visualizing arthritic inflammation and therapeutic response by fluorine-19 magnetic resonance imaging (19F MRI). J Inflamm (Lond) (2012) 0.88
Macrophage targeted theranostics as personalized nanomedicine strategies for inflammatory diseases. Theranostics (2015) 0.87
Two-color fluorescent (near-infrared and visible) triphasic perfluorocarbon nanoemuslions. J Biomed Opt (2013) 0.86
Imaging neuroinflammation in vivo in a neuropathic pain rat model with near-infrared fluorescence and ¹⁹F magnetic resonance. PLoS One (2014) 0.85
Imaging of intratumoral inflammation during oncolytic virotherapy of tumors by 19F-magnetic resonance imaging (MRI). PLoS One (2013) 0.83
Characterization of early neovascular response to acute lung ischemia using simultaneous (19)F/ (1)H MR molecular imaging. Angiogenesis (2013) 0.82
Optical imaging probes in oncology. Oncotarget (2016) 0.81
Theranostic nanoemulsions for macrophage COX-2 inhibition in a murine inflammation model. Clin Immunol (2015) 0.79
In Vivo (19)F MR Imaging Cell Tracking of Inflammatory Macrophages and Site-specific Development of Colitis-associated Dysplasia. Radiology (2016) 0.78
Fluorine-19 MRI Contrast Agents for Cell Tracking and Lung Imaging. Magn Reson Insights (2016) 0.77
Cell tracking using (19)F magnetic resonance imaging: technical aspects and challenges towards clinical applications. Eur Radiol (2014) 0.77
Interleukin-10-deficient mice develop chronic enterocolitis. Cell (1993) 22.57
Unravelling the pathogenesis of inflammatory bowel disease. Nature (2007) 18.52
Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications. J Immunol Methods (1994) 13.53
Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology (1997) 9.70
Increased expression of interleukin 17 in inflammatory bowel disease. Gut (2003) 9.16
Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses. J Clin Invest (1996) 7.97
The mechanism of action of cyclosporin A and FK506. Immunol Today (1992) 7.57
In vivo imaging platform for tracking immunotherapeutic cells. Nat Biotechnol (2005) 5.49
Sequence variants in IL10, ARPC2 and multiple other loci contribute to ulcerative colitis susceptibility. Nat Genet (2008) 5.05
Enhanced secretion of tumour necrosis factor-alpha, IL-6, and IL-1 beta by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease. Clin Exp Immunol (1993) 4.68
Inflammatory bowel disease: epidemiology, pathogenesis, and therapeutic opportunities. Inflamm Bowel Dis (2006) 4.29
Animal models of mucosal inflammation and their relation to human inflammatory bowel disease. Curr Opin Immunol (1999) 2.92
19F magnetic resonance imaging for stem/progenitor cell tracking with multiple unique perfluorocarbon nanobeacons. FASEB J (2007) 2.63
In vivo monitoring of inflammation after cardiac and cerebral ischemia by fluorine magnetic resonance imaging. Circulation (2008) 2.57
Pathogenesis and immune mechanisms of chronic inflammatory bowel diseases. Am J Gastroenterol (1997) 2.55
Immunoregulatory role of interleukin 10 in patients with inflammatory bowel disease. Gastroenterology (1995) 2.38
Predominant pathogenic role of tumor necrosis factor in experimental colitis in mice. Eur J Immunol (1997) 2.35
Neutralization of tumour necrosis factor (TNF) but not of IL-1 reduces inflammation in chronic dextran sulphate sodium-induced colitis in mice. Clin Exp Immunol (1997) 2.20
Fluorine-19 MRI for visualization and quantification of cell migration in a diabetes model. Magn Reson Med (2007) 2.18
In vivo wide-area cellular imaging by side-view endomicroscopy. Nat Methods (2010) 2.10
Cellular MR imaging. Mol Imaging (2005) 2.01
Self-delivering nanoemulsions for dual fluorine-19 MRI and fluorescence detection. J Am Chem Soc (2008) 1.84
Mechanisms of glucocorticoid action on immune processes. Annu Rev Pharmacol Toxicol (1979) 1.67
In vivo "hot spot" MR imaging of neural stem cells using fluorinated nanoparticles. Magn Reson Med (2008) 1.56
Amelioration of dextran sulfate sodium-induced colitis by anti-macrophage migration inhibitory factor antibody in mice. Gastroenterology (2002) 1.54
The key role of macrophages in the immunopathogenesis of inflammatory bowel disease. Inflamm Bowel Dis (2000) 1.53
Elimination of local macrophages in intestine prevents chronic colitis in interleukin-10-deficient mice. Dig Dis Sci (2003) 1.28
19F MRI detection of acute allograft rejection with in vivo perfluorocarbon labeling of immune cells. Magn Reson Med (2011) 1.27
MRI evaluation of inflammatory activity in Crohn's disease. AJR Am J Roentgenol (2005) 1.25
Functional assessment of human dendritic cells labeled for in vivo (19)F magnetic resonance imaging cell tracking. Cytotherapy (2010) 1.23
Early assessment of pulmonary inflammation by 19F MRI in vivo. Circ Cardiovasc Imaging (2010) 1.22
Therapy of inflammatory bowel disease. Gastroenterology (2000) 1.11
In vivo observation of intracellular oximetry in perfluorocarbon-labeled glioma cells and chemotherapeutic response in the CNS using fluorine-19 MRI. Magn Reson Med (2010) 1.10
Fluorine cardiovascular magnetic resonance angiography in vivo at 1.5 T with perfluorocarbon nanoparticle contrast agents. J Cardiovasc Magn Reson (2007) 1.07
Modern imaging using computer tomography and magnetic resonance imaging for inflammatory bowel disease (IBD) AU1. Inflamm Bowel Dis (2004) 1.07
Pilot study using PET/CT as a novel, noninvasive assessment of disease activity in inflammatory bowel disease. Inflamm Bowel Dis (2007) 1.07
Inflammation driven by overexpression of the hypoglycosylated abnormal mucin 1 (MUC1) links inflammatory bowel disease and pancreatitis. Pancreas (2010) 1.05
Substance P regulates Th1-type colitis in IL-10 knockout mice. J Immunol (2003) 1.04
Artificial oxygen carriers as red blood cell substitutes: a selected review and current status. Artif Organs (2004) 1.04
The role of the macrophage in sentinel responses in intestinal immunity. Curr Opin Gastroenterol (2010) 1.03
Rapid quantification of inflammation in tissue samples using perfluorocarbon emulsion and fluorine-19 nuclear magnetic resonance. Biotechniques (2011) 0.99
Perfluoro-15-crown-5-ether labelled macrophages in adoptive transfer experimental allergic encephalomyelitis. Artif Cells Blood Substit Immobil Biotechnol (1997) 0.98
Noninvasive detection of graft rejection by in vivo (19) F MRI in the early stage. Am J Transplant (2011) 0.98
Understanding clinical literature relevant to spontaneous intestinal perforations. Am J Perinatol (2008) 0.96
19F-MRI of perflubron for measurement of oxygen partial pressure in porcine lungs during partial liquid ventilation. Magn Reson Med (2002) 0.92
Cyclosporine regulates intestinal epithelial apoptosis via TGF-beta-related signaling. Am J Physiol Gastrointest Liver Physiol (2009) 0.90
The effect of dexamethasone treatment on murine colitis. Scand J Gastroenterol (2000) 0.90
Interleukin-10 promoter polymorphisms influence susceptibility to ulcerative colitis in a gender-specific manner. Scand J Gastroenterol (2008) 0.88
19F magnetic resonance imaging of the reticuloendothelial system. Magn Reson Med (1987) 0.80
Idiopathic inflammatory bowel disease: endoscopic-radiologic correlation. Radiology (1995) 0.79
A new transgene reporter for in vivo magnetic resonance imaging. Nat Med (2005) 2.85
Fluorine-19 MRI for visualization and quantification of cell migration in a diabetes model. Magn Reson Med (2007) 2.18
Transcriptomic and genomic analysis of human hepatocellular carcinomas and hepatoblastomas. Hepatology (2006) 2.08
Self-delivering nanoemulsions for dual fluorine-19 MRI and fluorescence detection. J Am Chem Soc (2008) 1.84
Vaccine against MUC1 antigen expressed in inflammatory bowel disease and cancer lessens colonic inflammation and prevents progression to colitis-associated colon cancer. Cancer Prev Res (Phila) (2010) 1.75
Fluorine-containing nanoemulsions for MRI cell tracking. Wiley Interdiscip Rev Nanomed Nanobiotechnol (2010) 1.61
Epidermal growth factor receptor: a novel target of the Wnt/beta-catenin pathway in liver. Gastroenterology (2005) 1.58
(19)F MRI for quantitative in vivo cell tracking. Trends Biotechnol (2010) 1.49
In vivo cytometry of antigen-specific t cells using 19F MRI. Magn Reson Med (2009) 1.44
Deregulation of Hippo kinase signalling in human hepatic malignancies. Liver Int (2011) 1.31
19F MRI detection of acute allograft rejection with in vivo perfluorocarbon labeling of immune cells. Magn Reson Med (2011) 1.27
Design and characterization of a chimeric ferritin with enhanced iron loading and transverse NMR relaxation rate. J Biol Inorg Chem (2010) 1.27
Functional assessment of human dendritic cells labeled for in vivo (19)F magnetic resonance imaging cell tracking. Cytotherapy (2010) 1.23
Non-invasive imaging of transplanted human neural stem cells and ECM scaffold remodeling in the stroke-damaged rat brain by (19)F- and diffusion-MRI. Biomaterials (2012) 1.22
In vivo magnetic resonance imaging of ferritin-based reporter visualizes native neuroblast migration. Neuroimage (2011) 1.18
In vivo observation of intracellular oximetry in perfluorocarbon-labeled glioma cells and chemotherapeutic response in the CNS using fluorine-19 MRI. Magn Reson Med (2010) 1.10
Anatomical analysis of an aye-aye brain (Daubentonia madagascariensis, primates: Prosimii) combining histology, structural magnetic resonance imaging, and diffusion-tensor imaging. Anat Rec A Discov Mol Cell Evol Biol (2005) 1.08
A spontaneous intramural hematoma of the bowel presenting as obstruction in a child receiving low-molecular-weight heparin. J Pediatr Hematol Oncol (2005) 1.06
Inflammation driven by overexpression of the hypoglycosylated abnormal mucin 1 (MUC1) links inflammatory bowel disease and pancreatitis. Pancreas (2010) 1.05
Further evidence for EpCAM as the gene for congenital tufting enteropathy. Am J Med Genet A (2010) 1.03
Genetic polymorphisms impact the risk of acute rejection in pediatric heart transplantation: a multi-institutional study. Transplantation (2008) 1.03
A novel (19)F agent for detection and quantification of human dendritic cells using magnetic resonance imaging. Int J Cancer (2010) 1.01
Theoretical MRI contrast model for exogenous T2 agents. Magn Reson Med (2007) 1.00
Pediatric small bowel transplantation. Semin Pediatr Surg (2010) 1.00
Rapid quantification of inflammation in tissue samples using perfluorocarbon emulsion and fluorine-19 nuclear magnetic resonance. Biotechniques (2011) 0.99
Sex-specific, postpuberty changes in mouse brain structures revealed by three-dimensional magnetic resonance microscopy. Neuroimage (2004) 0.97
Sensitive and automated detection of iron-oxide-labeled cells using phase image cross-correlation analysis. Magn Reson Imaging (2008) 0.94
Intracellular pH measurements using perfluorocarbon nanoemulsions. J Am Chem Soc (2013) 0.94
Analysis of spatial and temporal dynamics of xylem refilling in Acer rubrum L. using magnetic resonance imaging. Front Plant Sci (2013) 0.94
Neonatal lingual choristoma with respiratory and gastric epithelium. Arch Otolaryngol Head Neck Surg (2002) 0.92
A pilot study of low-dose anti-angiogenic chemotherapy in combination with standard multiagent chemotherapy for patients with newly diagnosed metastatic Ewing sarcoma family of tumors: A Children's Oncology Group (COG) Phase II study NCT00061893. Pediatr Blood Cancer (2012) 0.91
Profound phenotypic variation among mice deficient in the maintenance of genomic imprints. Hum Reprod (2008) 0.91
Aberrant expression of MUC1 mucin in pediatric inflammatory bowel disease. Pediatr Dev Pathol (2010) 0.91
First application of extremely high-resolution magnetic resonance imaging to study microscopic features of normal and LHON human optic nerve. Ophthalmology (2002) 0.90
Accelerated fluorine-19 MRI cell tracking using compressed sensing. Magn Reson Med (2012) 0.89
Visualizing arthritic inflammation and therapeutic response by fluorine-19 magnetic resonance imaging (19F MRI). J Inflamm (Lond) (2012) 0.88
Gene expression analysis of dendritic cells that prevent diabetes in NOD mice: analysis of chemokines and costimulatory molecules. J Leukoc Biol (2011) 0.87
Analysis of national and single-center incidence and survival after liver transplantation for hepatoblastoma: new trends and future opportunities. Surgery (2013) 0.86
Increased expression of peripheral blood leukocyte genes implicate CD14+ tissue macrophages in cellular intestine allograft rejection. Am J Pathol (2011) 0.86
Gene polymorphisms impact the risk of rejection with hemodynamic compromise: a multicenter study. Transplantation (2011) 0.85
Prevention of colitis-associated colon cancer using a vaccine to target abnormal expression of the MUC1 tumor antigen. Oncoimmunology (2012) 0.84
Semiquantitative histopathology and 3D magnetic resonance microscopy as collaborative platforms for tissue identification and comparison within teratomas derived from pedigreed primate embryonic stem cells. Stem Cell Res (2010) 0.84
Engineered mitochondrial ferritin as a magnetic resonance imaging reporter in mouse olfactory epithelium. PLoS One (2013) 0.83
Calpain induces N-terminal truncation of β-catenin in normal murine liver development: diagnostic implications in hepatoblastomas. J Biol Chem (2012) 0.83
Refinement of under-determined loops of Human Prion Protein by database-derived distance constraints. Int J Data Min Bioinform (2009) 0.83
Functional screening of guide RNAs targeting the regulatory and structural HIV-1 viral genome for a cure of AIDS. AIDS (2016) 0.82
Allospecific CD154 + T-cytotoxic memory cells as potential surrogate for rejection risk in pediatric intestine transplantation. Pediatr Transplant (2011) 0.82
Infantile systemic lupus erythematosus presenting with pulmonary hemorrhage. Pediatr Nephrol (2005) 0.82
Postpubertal sex differentiation of forebrain structures and functions depend on transforming growth factor-alpha. J Neurosci (2005) 0.82
Absent smooth muscle actin immunoreactivity of the small bowel muscularis propria circular layer in association with chromosome 15q11 deletion in megacystis-microcolon-intestinal hypoperistalsis syndrome. Pediatr Dev Pathol (2010) 0.82
Automated detection and characterization of SPIO-labeled cells and capsules using magnetic field perturbations. Magn Reson Med (2011) 0.81
Paratesticular rhabdomyoma in a young adult: case study and review of the literature. J Pediatr Surg (2007) 0.80
Simultaneous Adrenocortical Carcinoma and Neuroblastoma in an Infant With a Novel Germline p53 Mutation. J Pediatr Hematol Oncol (2015) 0.80
In vivo intracellular oxygen dynamics in murine brain glioma and immunotherapeutic response of cytotoxic T cells observed by fluorine-19 magnetic resonance imaging. PLoS One (2013) 0.79
Enhanced positive-contrast visualization of paramagnetic contrast agents using phase images. Magn Reson Med (2009) 0.79
Adenovirus infection within stromal cells in a pediatric small bowel allograft. Pediatr Dev Pathol (2006) 0.77
Recurrence of primary sclerosing cholangitis in pediatric liver transplant recipients. Liver Transpl (2014) 0.77
NOVEL ADVANCES IN UNDERSTANDING OF MOLECULAR PATHOGENESIS OF HEPATOBLASTOMA: A WNT/BETA-CATENIN PERSPECTIVE! Gene Expr (2016) 0.77
U6 promoter-enhanced GlnUAG suppressor tRNA has higher suppression efficacy and can be stably expressed in 293 cells. J Gene Med (2013) 0.76
Mucosal plasma cell barrier disruption during intestine transplant rejection. Transplantation (2012) 0.76
Clear cell sarcoma of the kidney in a child with Fanconi anemia. Pediatr Dev Pathol (2014) 0.76
Autoimmunity, alloimmunity, and chronic liver allograft injury. Pediatr Transplant (2012) 0.75
Dietary Supplementation With Nonfermentable Fiber Alters the Gut Microbiota and Confers Protection in Murine Models of Sepsis. Crit Care Med (2017) 0.75
Predicting Cellular Rejection With a Cell-Based Assay: Preclinical Evaluation in Children. Transplantation (2016) 0.75
Key Histopathologic Features of Liver Biopsies That Distinguish Biliary Atresia From Other Causes of Infantile Cholestasis and Their Correlation With Outcome: A Multicenter Study. Am J Surg Pathol (2016) 0.75
Bilateral Epstein-Barr virus-associated adrenal leiomyomas in a child without an established immunodeficiency. Pediatr Dev Pathol (2012) 0.75
Staphylococcus aureus panniculitis complicating juvenile dermatomyositis. Pediatrics (2007) 0.75
IBD LIVE Case Series-Case 3: Very Early-Onset Inflammatory Bowel Disease: When Genetic Testing Proves Beneficial. Inflamm Bowel Dis (2015) 0.75
The challenges of liver transplantation in children with primary sclerosing cholangitis. Expert Rev Gastroenterol Hepatol (2015) 0.75
Genomic Characterization of a Metastatic Alveolar Rhabdomyosarcoma Case Using FISH Studies and CGH+SNP Microarray Revealing FOXO1-PAX7 Rearrangement with MYCN and MDM2 Amplification and RB1 Region Loss. Cytogenet Genome Res (2017) 0.75
Reverse referral: from pathology to endocrinology. Endocr Pathol (2009) 0.75
Pathology of the gallbladder in a child with metachromatic leukodystrophy. Pediatr Dev Pathol (2015) 0.75
Teratoid hepatoblastoma with abundant cholangioblastic component in a child with full trisomy 13. Pediatr Dev Pathol (2013) 0.75
Emerging non-invasive imaging techniques using magnetic resonance imaging. Curr Top Dev Biol (2005) 0.75
A case of luteinizing thecoma with sclerosing peritonitis: revisiting a link with anti-epileptic drugs. Pediatr Blood Cancer (2010) 0.75